To assess oncolytic activity in vivo, we tested Ad5/MUC16-1040/TK-EGFP in an ovarian cancer xenograft mouse model using NOD-scid IL2Rgammanull (NSG) immunodeficient mice. This evidence concerns the gene MUC16 and ovarian carcinoma.